GLP-1 Agonists

Cagrilintide (NN9838, formerly known as AM833) is a long-acting amylin analog developed by Novo Nord...

A novel triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously....

First-in-class dual GIP/GLP-1 receptor agonist (Mounjaro®/Zepbound®) achieving up to 22.5% weight lo...